Aravax
Biotechnology Research
Melbourne, Victoria, Au
13 employees
- Employees
- 13
- Contacts
- 3
- Emails
- 3
Aravax Overview
- Headquarters
- Melbourne, Victoria, Au
- Phone Number
- Available in AeroLeads
- Website
- aravax.com.au
- Industry
- Biotechnology Research
- Employees
- 13
- Funding
- 22.2M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Aravax
Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience.
Aravax Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Aravax Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Pascal Hickey | CEO at Aravax Pty Ltd | Melbourne, Victoria, Australia |
Email
|
| Thomas Ulmer | Seasoned Leader in Healthcare, Life | Australia |
Email
|
| Aled Williams | Chief Executive Officer / Non-executive |
View
|
|
| Adrian Parry | Director of Cmc, Aravax | Greater Oxford Area, United Kingdom |
Email
|
Employees by Management Level
Executive
3 profiles
Director
2 profiles
Individual contributor
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| Executive | 2 | 2 | 0 |
Compare Similar Companies to Aravax
Telix Pharmaceuticals Limited
Pharmaceutical Manufacturing
Nutromics
Medical Equipment Manufacturing
Brandon Capital
Venture Capital And Private Equity Principals
Atmo Biosciences
Biotechnology Research
Certa Therapeutics
Biotechnology Research
Currus Biologics Pty Ltd
Biotechnology Research
ENA Respiratory
Pharmaceutical Manufacturing
Tenmile
Financial Services
Denteric Pty Ltd
Biotechnology Research
PROTA THERAPEUTICS PTY LTD
Research Services